Last reviewed · How we verify

NCT05263011: AVOC4

Avocado Snacks in a Prediabetic Population

Completed NA Last updated 8 May 2025
What this trial tests

NA trial testing Avocado in PreDiabetes in 50 participants. Completed in 1 April 2025.

Timeline
1 June 2022
Primary endpoint
30 September 2023
1 April 2025

Quick facts

Lead sponsorClinical Nutrition Research Center, Illinois Institute of Technology
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeother
Enrollment50
Start date1 June 2022
Primary completion30 September 2023
Estimated completion1 April 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Clinical Nutrition Research Center, Illinois Institute of Technology — full company profile →

Who can join

Adults 25 to 70, any sex, with PreDiabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Compare the effects of three evening snacks on morning fasting and postprandial glucose and insulin concentrations in individuals with prediabetes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Using the Avocado as an Evening Snack to Investigate Whole Food Matrix and Macronutrient Composition on Morning Metabolic Indices in Adults With Prediabetes.
    Preiss C, Marquis O, Edirisinghe I, Burton-Freeman BM. · · 2025 · PMID 40689342 · DOI 10.1016/j.cdnut.2025.107486

Verify or expand the search:

Other trials of Avocado

Trials testing the same drug.

Other recruiting trials for PreDiabetes

Currently open trials in the same condition.

Other Clinical Nutrition Research Center, Illinois Institute of Technology trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05263011.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing